NAD+ Oral Supplement Pilot Intervention in Adult Females

Last updated: June 9, 2025
Sponsor: University of Rhode Island
Overall Status: Active - Recruiting

Phase

N/A

Condition

Inflammation

Multiple Sclerosis

Neurologic Disorders

Treatment

Nicotinamide adenine dinucleotide

Clinical Study ID

NCT06579209
2087241-4
P20GM103430
  • Ages 40-80
  • Female
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to learn if Nicotinamide adenine dinucleotide (NAD+) can influence cognition and biomarkers in healthy, cognitively intact women who identify as Latina and are between the ages of 40-80. The main questions it aims to answer are:

Will executive function change in response to NAD+? Will inflammatory markers and serum indicators of neurodegeneration change in response to NAD+? Researchers will compare individuals receiving the NAD+ to see if the results differ from those receiving the placebo.

Participants will:

Complete an online questionnaire, Visit the lab for computerized cognitive testing and a blood draw, Take NAD+ or a placebo every day for 4 weeks, Visit the lab for computerized cognitive testing and a blood draw

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Identify as Latina, have three or more adverse childhood experiences, and a BMI of 18.5 or above

Exclusion

Exclusion Criteria:

  • Those who are taking hormone medication, pregnant or breastfeeding

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Nicotinamide adenine dinucleotide
Phase:
Study Start date:
December 01, 2024
Estimated Completion Date:
September 01, 2025

Connect with a study center

  • University of Rhode Island

    Kingston, Rhode Island 02881
    United States

    Active - Recruiting

  • Independence Square, University of Rhode Island

    Pawtucket, Rhode Island 02860
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.